ArticleFrontiers in medicine2026
Fetal growth in PCOS pregnancies: dynamic evidence of restriction and the modifying role of ART.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03220750 (University Hospital Advanced Age Pregnant Cohort), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
University Hospital Advanced Age Pregnant Cohort
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS), the most prevalent endocrine disorder among women of reproductive age, is associated with adverse pregnancy outcomes. However, the dynamic trajectory of fetal growth in PCOS pregnancies remains inadequately characterized. Objective: This study aimed to longitudinally assess fetal growth in PCOS pregnancies and evaluate whether assisted reproductive technology (ART) modifies associated fetal growth restriction. Methods: In this prospective multicenter cohort study (UNIHOPE; NCT03220750), 12,189 advanced maternal age pregnancies (364 with Rotterdam-diagnosed PCOS) underwent longitudinal fetal biometry in the second and third trimesters following ISUOG guidelines. Z-scores were derived using the study's advanced-age reference, adjusting for gestational age and sex. Generalized linear models were adjusted for maternal demographics, lifestyle factors, and gestational diabetes mellitus, with subgroup analyses stratified by ART conception. Results: Among 12,189 advanced maternal age pregnancies (364 PCOS), PCOS fetuses showed reduced second-trimester Z-scores for femur length (MD: -0.13; 95% CI, -0.25 to -0.02) and head circumference (MD: -0.14; 95% CI, -0.23 to -0.04), with third-trimester deficits extending to biparietal diameter (MD: -0.18) and abdominal circumference (MD: -0.16). Birth length (MD: -0.16) and weight (MD: -0.13) Z-scores were lower in PCOS neonates. Growth restriction was evident only in spontaneous conceptions, with no significant differences in ART-conceived pregnancies. Findings were robust to GDM adjustment. Discussion: Fetal growth restriction in PCOS pregnancies is detectable from the second trimester and persists to delivery. ART conception appears to mitigate this restriction, yielding fetal growth parameters comparable to the reference population. These findings underscore the necessity of dynamic ultrasound surveillance in PCOS pregnancies and highlight a potential protective role of ART in perinatal outcomes. Clinical trial registration: https://clinicaltrials.gov, identifier NCT03220750.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.